Engineering Biomaterials with Micro/Nanotechnologies for Cell Reprogramming.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 32011856.
- Also identified by DOI 10.1021/acsnano.9b04837 and PMC identifier 10067273.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cell reprogramming is a revolutionized biotechnology that offers a powerful tool to engineer cell fate and function for regenerative medicine, disease modeling, drug discovery, and beyond. Leveraging advances in biomaterials and micro/nanotechnologies can enhance the reprogramming performance <i>in vitro</i> and <i>in vivo</i> through the development of delivery strategies and the control of biophysical and biochemical cues. In this review, we present an overview of the state-of-the-art technologies for cell reprogramming and highlight the recent breakthroughs in engineering biomaterials with micro/nanotechnologies to improve reprogramming efficiency and quality. Finally, we discuss future directions and challenges for reprogramming technologies and clinical translation.
Medical subject headings
- Biocompatible Materials
- Nanotechnology
- Tissue Engineering